| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0090-4295(03)00776-3 |
| P698 | PubMed publication ID | 14607212 |
| P50 | author | Tapio Visakorpi | Q49957442 |
| P2093 | author name string | Tapio Visakorpi | |
| P2860 | cites work | Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer | Q24685619 |
| Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 | ||
| A candidate prostate cancer susceptibility gene at chromosome 17p | Q28200053 | ||
| KLF6, a candidate tumor suppressor gene mutated in prostate cancer | Q28213009 | ||
| Identification of a variant associated with adult-type hypolactasia | Q28215372 | ||
| Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 | Q28215945 | ||
| Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search | Q28296089 | ||
| Roles for Nkx3.1 in prostate development and cancer | Q28586102 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression | Q33944717 | ||
| Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays. | Q34127887 | ||
| Evidence for a prostate cancer-susceptibility locus on chromosome 20. | Q34141928 | ||
| Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer | Q34145106 | ||
| A genome screen of multiplex sibships with prostate cancer. | Q34145438 | ||
| Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. | Q34389120 | ||
| Perspective: prostate cancer susceptibility genes | Q34646957 | ||
| Genetic alterations in hormone-refractory recurrent prostate carcinomas | Q35753171 | ||
| Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer | Q35764687 | ||
| Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. | Q35787051 | ||
| A new type of mutation causes a splicing defect in ATM. | Q40745220 | ||
| Cancer statistics, 1999. | Q40817780 | ||
| A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. | Q41615181 | ||
| Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis | Q41899984 | ||
| Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43 | Q42071652 | ||
| ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER | Q57274821 | ||
| Evidence for a prostate cancer susceptibility locus on the X chromosome. | Q57274826 | ||
| Molecular genetics of prostate cancer | Q58136321 | ||
| New pieces to the prostate cancer puzzle | Q74623236 | ||
| Expression profiling using cDNA microarrays | Q77895878 | ||
| P433 | issue | 5 Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular genetics | Q210506 |
| prostate cancer | Q181257 | ||
| P304 | page(s) | 3-10 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | The molecular genetics of prostate cancer | |
| P478 | volume | 62 |
| Q38989441 | A novel approach to identify driver genes involved in androgen-independent prostate cancer |
| Q36994781 | Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis |
| Q37460521 | Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium |
| Q47233293 | Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships |
| Q54401185 | Are GSTM1, GSTT1 and CAG repeat length of androgen receptor gene polymorphisms associated with risk of prostate cancer in Iranian patients? |
| Q34495274 | Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success |
| Q43948180 | CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. |
| Q35715762 | Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors |
| Q40534583 | Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation. |
| Q36463216 | Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification |
| Q36845131 | Genomic biomarkers, androgen pathway and prostate cancer. |
| Q53343330 | Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. |
| Q46875485 | ICAM gene cluster SNPs and prostate cancer risk in African Americans. |
| Q30492997 | Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer |
| Q36385691 | Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells. |
| Q28943507 | Multiple loci identified in a genome-wide association study of prostate cancer |
| Q36194953 | Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens |
| Q37330766 | Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial |
| Q44403510 | Prostate cancer susceptibility genes on 8p21-23 in a Dutch population |
| Q57174381 | Quantitative Analysis of Seven New Prostate Cancer Biomarkers and the Potential Future of the 'Biomarker Laboratory' |
| Q38292912 | RHEB expression in fibroadenomas of the breast |
| Q83077012 | Racial disparities in urologic health care |
| Q91714772 | Recognizing and stabilizing miR-21 by chiral ruthenium(II) complexes |
| Q36167592 | Repopulation of cancer cells during therapy: an important cause of treatment failure |
| Q38615715 | Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC). |
| Q36415100 | Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology |
| Q27651007 | The SOCS Box Domain of SOCS3: Structure and Interaction with the ElonginBC-Cullin5 Ubiquitin Ligase |
| Q81580780 | The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth |
| Q38868194 | The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer |
Search more.